Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
The Journal of Experimental Medicine|September 9, 1998
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cellsB Bodaghi, T R Jones, D Zipeto, et al.
Cell Death and Differentiation|November 6, 2010
Modulation of CD4+ T-cell activation by CD95 co-stimulationM Paulsen, S Valentin, B Mathew, et al.
Chemical Communications (Cambridge, England)|October 9, 2023
β-Galactosidase-activated nitroxyl (HNO) donors provide insights into redox cross-talk in senescent cellsLaxman R Sawase, T Anand Kumar, Abraham B Mathew, et al.
Journal of Medicinal Chemistry|April 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modificationsT R Jones, M J Smithers, M A Taylor, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|April 20, 2000
Humoral immune responses against Plasmodium vivax MSP1 in humans living in a malaria endemic area in Flores, IndonesiaM Ak, T R Jones, Y Charoenvit, et al.
BMC Nephrology|October 19, 2019
Association of medication non-adherence with short-term allograft loss after the treatment of severe acute kidney transplant rejectionAhmed Al-Sheyyab, Laura Binari, Mohammed Shwetar, et al.
The American Journal of Tropical Medicine and Hygiene|June 1, 1997
Assessment of age-dependent immunity to malaria in transmigrantsE Andersen, T R Jones, Purnomo, et al.
Immunity|May 1, 1997
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAPK Ahn, A Gruhler, B Galocha, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acidR Zamboni, M Belley, E Champion, et al.
Vaccine|August 9, 2012
A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trialP C Richmond, M D Nissen, H S Marshall, et al.
Pageof 33